Insider trade

Director received an award of 2,286 ABT shares

Traded Apr 24, 2026 · Filed Apr 28, 2026

Abbott LaboratoriesABT

2,286
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 24, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 28, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000902132-26-000005
Filed / recorded

Apr 28, 2026, 11:37 PM UTC

Added to OQRO

Oct 2, 2026, 12:26 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

ABBOTT LABORATORIES

Issuer CIK

1800

Ticker

ABT

Reporting person

Daniel J Starks

Relationship

Director

Security

Common shares without par value

Table

Non-derivative (Table I)

Transaction date

Apr 24, 2026

Transaction code

A

Shares / units

2,286

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

6,741,103

Ownership form

Direct

Amendment

No

Footnotes from the filing

Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).